Transglutaminase 2 exacerbates ovarian cancer survival by directly inactivating GSK3β
- DOI
- 10.1038/s41419-026-08447-0
- Published
- 2026-02-02
- Container
- Cell Death & Disease
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41419-026-08447-0,
title = {Transglutaminase 2 exacerbates ovarian cancer survival by directly inactivating GSK3β},
author = {Ho Lee and Joon Hee Kang and Hyun Jung Kim and Kyun Heo and Mi Kyung Park and Jeong Hwan Park and Byung Il Lee and Jong In Yook and Soo-Youl Kim},
year = {2026},
journal = {Cell Death \& Disease},
doi = {10.1038/s41419-026-08447-0},
url = {https://doi.org/10.1038/s41419-026-08447-0}
}RIS
TY - JOUR TI - Transglutaminase 2 exacerbates ovarian cancer survival by directly inactivating GSK3β AU - Ho Lee AU - Joon Hee Kang AU - Hyun Jung Kim AU - Kyun Heo AU - Mi Kyung Park AU - Jeong Hwan Park AU - Byung Il Lee AU - Jong In Yook AU - Soo-Youl Kim PY - 2026 JO - Cell Death & Disease DO - 10.1038/s41419-026-08447-0 UR - https://doi.org/10.1038/s41419-026-08447-0 ER -
APA
Lee, H., Kang, J. H., Kim, H. J., Heo, K., Park, M. K., Park, J. H., Lee, B. I., Yook, J. I., & Kim, S. (2026). Transglutaminase 2 exacerbates ovarian cancer survival by directly inactivating GSK3β. Cell Death & Disease. https://doi.org/10.1038/s41419-026-08447-0
Source records
- crossref · retrieved 2026-09-26T14:13:10.204Z